Strides Shasun surges on getting USFDA’s nod for Memantine Hydrochloride Tablets

25 May 2017 Evaluate

Strides Shasun is currently trading at Rs. 900.50, up by 18.05 points or 2.05% from its previous closing of Rs. 882.45 on the BSE.

The scrip opened at Rs. 890.00 and has touched a high and low of Rs. 906.55 and Rs. 877.00 respectively. So far 27489 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1259.00 on 03-Feb-2017 and a 52 week low of Rs. 848.50 on 24-May-2017.

Last one week high and low of the scrip stood at Rs. 1069.00 and Rs. 848.50 respectively. The current market cap of the company is Rs. 8025.71 crore.

The promoters holding in the company stood at 31.09%, while Institutions and Non-Institutions held 48.89% and 20.02% respectively.

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg. Memantine Hydrochloride Tablets are indicated for the treatment of moderate to severe Alzheimer-type dementia

The US market for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg is around $60 million. The product will be manufactured at the company’s flagship facility at Bangalore and marketed by Strides Pharma Inc in the US Market. The product will be launched immediately.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.


Strides Pharma Scien Share Price

815.05 18.85 (2.37%)
29-Jan-2026 11:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.90
Dr. Reddys Lab 1203.90
Cipla 1319.80
Zydus Lifesciences 887.90
Lupin 2117.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×